CCNA2 and breast carcinoma: Specifically, Nek5 was shown to enhance breast cancer cell mesenchymal morphology and migration [134], and was also shown to enhance breast cancer cell proliferation via upregulation of Cyclin A2 expression, while downregulating Cyclin D1, D3, and E1 expression [135].